SRRA
Dimensional Fund Advisors’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-44,204
| Closed | -$1.42M | – | 3563 |
|
|
2022
Q1 | $1.42M | Buy |
44,204
+4,899
| +12% | +$157K | ﹤0.01% | 2910 |
|
|
2021
Q4 | $854K | Buy |
39,305
+16,208
| +70% | +$352K | ﹤0.01% | 3062 |
|
|
2021
Q3 | $506K | Buy |
23,097
+4,968
| +27% | +$109K | ﹤0.01% | 3176 |
|
|
2021
Q2 | $354K | Buy |
18,129
+440
| +2% | +$8.59K | ﹤0.01% | 3232 |
|
|
2021
Q1 | $305K | Buy |
17,689
+4,242
| +32% | +$73.1K | ﹤0.01% | 3225 |
|
|
2020
Q4 | $216K | Buy |
13,447
+267
| +2% | +$4.29K | ﹤0.01% | 3209 |
|
|
2020
Q3 | $141K | Sell |
13,180
-77
| -0.6% | -$824 | ﹤0.01% | 3238 |
|
|
2020
Q2 | $161K | Buy |
13,257
+2,473
| +23% | +$30K | ﹤0.01% | 3234 |
|
|
2020
Q1 | $106K | Buy |
+10,784
| New | +$106K | ﹤0.01% | 3268 |
|
|
2019
Q4 | – | Sell |
-118,257
| Closed | -$46K | – | 3416 |
|
|
2019
Q3 | $46K | Sell |
118,257
-867,880
| -88% | -$338K | ﹤0.01% | 3386 |
|
|
2019
Q2 | $552K | Hold |
986,137
| – | – | ﹤0.01% | 3172 |
|
|
2019
Q1 | $1.69M | Sell |
986,137
-23,667
| -2% | -$40.5K | ﹤0.01% | 2930 |
|
|
2018
Q4 | $1.33M | Sell |
1,009,804
-38,142
| -4% | -$50.4K | ﹤0.01% | 2958 |
|
|
2018
Q3 | $1.78M | Buy |
1,047,946
+8,398
| +0.8% | +$14.3K | ﹤0.01% | 2949 |
|
|
2018
Q2 | $3.08M | Buy |
1,039,548
+287,357
| +38% | +$851K | ﹤0.01% | 2781 |
|
|
2018
Q1 | $1.56M | Buy |
752,191
+475,288
| +172% | +$984K | ﹤0.01% | 2909 |
|
|
2017
Q4 | $1.03M | Buy |
+276,903
| New | +$1.03M | ﹤0.01% | 2988 |
|